Literature DB >> 22118700

Probiotics in the management of gastrointestinal disease: analysis of the attitudes and prescribing practices of gastroenterologists and surgeons.

Claire Cordina1, Irshad Shaikh, Sussie Shrestha, John Camilleri-Brennan.   

Abstract

OBJECTIVE: Probiotics are increasingly advocated in the management of various gastrointestinal disorders. The aim of this study was to investigate the current attitudes and prescribing practices of surgeons and gastroenterologists for probiotics in the treatment of gastrointestinal disorders.
METHODS: A questionnaire was designed to look at the frequency of probiotic prescribing, types of probiotics used, indications for and duration of treatment and clinicians' experiences with probiotic use. A total of 220 questionnaires were mailed to consultant gastroenterologists and surgeons practicing in the UK.
RESULTS: The overall response rate was 80.5%, of which 69.5% of respondents said they recommended or prescribed probiotic food supplements to their patients, including 53.4% of surgeons and 80.8% of gastroenterologists (P = 0.00013). The most popular probiotic supplements among surgeons were probiotic-containing yoghurt and drinks (79.5% and 71.8%, respectively), whereas VSL#3 was more popular with gastroenterologists (83.3%). The most popular indications were irritable bowel syndrome (70.7% of prescribers) and pouchitis (67.5% of prescribers). Many respondents prescribed long-term probiotics. Most consultants had been prescribing probiotics for a period of 1 to 5 years.
CONCLUSION: Probiotics are popular among gastroenterologists and surgeons in the UK for the treatment of gastrointestinal disorders. Further evidence to support their routine use, by way of large, well-designed randomized controlled trials, is necessary.
© 2011 The Authors. Journal of Digestive Diseases © 2011 Chinese Medical Association Shanghai Branch, Chinese Society of Gastroenterology, Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine and Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 22118700     DOI: 10.1111/j.1751-2980.2011.00534.x

Source DB:  PubMed          Journal:  J Dig Dis        ISSN: 1751-2972            Impact factor:   2.325


  4 in total

1.  Exploring clinicians' attitudes about using aspirin for risk reduction in people with Lynch Syndrome with no personal diagnosis of colorectal cancer.

Authors:  Yanni Chen; Michelle Peate; Rajneesh Kaur; Bettina Meiser; Tim Wong; Judy Kirk; Robyn L Ward; Annabel Goodwin; Finlay Macrae; Janet Hiller; Alison H Trainer; Gillian Mitchell
Journal:  Fam Cancer       Date:  2017-01       Impact factor: 2.375

2.  Knowledge, attitudes, and understanding of probiotics among pediatricians in different regions of Saudi Arabia.

Authors:  Mohammed Hasosah; Mansour Qurashi; Abdullah Balkhair; Ziyad Alzahrani; Abdullah Alabbasi; Muhanad Alzahrani; Wejdan Alnahdi; Sohaib Shafei; Malak Bafaqih; Muhammad Khan
Journal:  BMC Med Educ       Date:  2021-01-21       Impact factor: 2.463

3.  Long-term use of probiotics Lactobacillus and Bifidobacterium has a prophylactic effect on the occurrence and severity of pouchitis: a randomized prospective study.

Authors:  Banasiewicz Tomasz; Stojcev Zoran; Walkowiak Jarosław; Marciniak Ryszard; Grochowalski Marcin; Burdyński Robert; Krokowicz Piotr; Krokowicz Lukasz; Paszkowski Jacek; Gronek Piotr; Pyda Przemysław; Drews Michał
Journal:  Biomed Res Int       Date:  2014-01-21       Impact factor: 3.411

Review 4.  Systematic review: probiotics in the management of lower gastrointestinal symptoms in clinical practice -- an evidence-based international guide.

Authors:  A P S Hungin; C Mulligan; B Pot; P Whorwell; L Agréus; P Fracasso; C Lionis; J Mendive; J-M Philippart de Foy; G Rubin; C Winchester; N de Wit
Journal:  Aliment Pharmacol Ther       Date:  2013-08-27       Impact factor: 8.171

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.